US Patent 10588973 Percutaneous absorption composition
Patent 10588973 was granted and assigned to MEDRx on March, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+447 characters)
Article
Patent abstract
The embodiments provide a percutaneous absorption composition for a basic medicament having improved transdermal absorbability. The percutaneous absorption composition comprises a sorbic acid and/or a metal sorbate as a percutaneous absorption promotor. The molar ration of the sorbic acid and/or the metal sorbate to the basic medicament is 0.5-2.5. The composition of the present disclosure may further comprise a basic component.
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105889730
Date of Patent
March 17, 2020
0Patent Application Number
159603920
Date Filed
April 23, 2018
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105889730
Date of Patent
March 17, 2020
0Patent Application Number
159603920
Date Filed
April 23, 2018
0Patent Primary Examiner
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10588973 Percutaneous absorption composition
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10588973
Date of patent
March 17, 2020
Patent application number
15960392
Date Filed
April 23, 2018
Patent primary examiner
Find more entities like US Patent 10588973 Percutaneous absorption composition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.